co-presented by
ASSOCIATE SPONSORS
co-presented by
ASSOCIATE SPONSORS
Strides, Pfizer to deal post US FDA nod on Oncology unit
Won't cut retail exposure till interest low: Motilal Oswal
IDFC says execution challenges in infra projects escalating
Infosys top-brass reshuffle not purely ornamental: Analyst
HyperCity margin pressure will get contained: Shoppers Stop
Sterlite Tech eyes 32-35% revenue increase ahead
Will maintain margins as cotton prices slip: Alok Ind
Bajaj Auto will not take any more price hikes for now
Crompton Greaves has target of Rs 225-220: Thukral
Strides, Pfizer to deal post US FDA nod on Oncology unit
Won't cut retail exposure till interest low: Motilal Oswal
IDFC says execution challenges in infra projects escalating
Infosys top-brass reshuffle not purely ornamental: Analyst
HyperCity margin pressure will get contained: Shoppers Stop
Sterlite Tech eyes 32-35% revenue increase ahead
Will maintain margins as cotton prices slip: Alok Ind
Bajaj Auto will not take any more price hikes for now
Crompton Greaves has target of Rs 225-220: Thukral
Strides, Pfizer to deal post US FDA nod on Oncology unit
Won't cut retail exposure till interest low: Motilal Oswal
IDFC says execution challenges in infra projects escalating
Infosys top-brass reshuffle not purely ornamental: Analyst
HyperCity margin pressure will get contained: Shoppers Stop
Sterlite Tech eyes 32-35% revenue increase ahead
Will maintain margins as cotton prices slip: Alok Ind
Bajaj Auto will not take any more price hikes for now
Crompton Greaves has target of Rs 225-220: Thukral
Strides, Pfizer to deal post US FDA nod on Oncology unit
Won't cut retail exposure till interest low: Motilal Oswal
IDFC says execution challenges in infra projects escalating
Infosys top-brass reshuffle not purely ornamental: Analyst
HyperCity margin pressure will get contained: Shoppers Stop
Sterlite Tech eyes 32-35% revenue increase ahead
Will maintain margins as cotton prices slip: Alok Ind
Bajaj Auto will not take any more price hikes for now
Crompton Greaves has target of Rs 225-220: Thukral
Strides, Pfizer to deal post US FDA nod on Oncology unit
Won't cut retail exposure till interest low: Motilal Oswal
IDFC says execution challenges in infra projects escalating
Infosys top-brass reshuffle not purely ornamental: Analyst
HyperCity margin pressure will get contained: Shoppers Stop
Sterlite Tech eyes 32-35% revenue increase ahead
Will maintain margins as cotton prices slip: Alok Ind
Bajaj Auto will not take any more price hikes for now
Crompton Greaves has target of Rs 225-220: Thukral
Strides, Pfizer to deal post US FDA nod on Oncology unit
Won't cut retail exposure till interest low: Motilal Oswal
IDFC says execution challenges in infra projects escalating
Infosys top-brass reshuffle not purely ornamental: Analyst
HyperCity margin pressure will get contained: Shoppers Stop
Sterlite Tech eyes 32-35% revenue increase ahead
Will maintain margins as cotton prices slip: Alok Ind
Bajaj Auto will not take any more price hikes for now
Crompton Greaves has target of Rs 225-220: Thukral
Strides, Pfizer to deal post US FDA nod on Oncology unit
Won't cut retail exposure till interest low: Motilal Oswal
IDFC says execution challenges in infra projects escalating
Infosys top-brass reshuffle not purely ornamental: Analyst
HyperCity margin pressure will get contained: Shoppers Stop
Sterlite Tech eyes 32-35% revenue increase ahead
Will maintain margins as cotton prices slip: Alok Ind
Bajaj Auto will not take any more price hikes for now
Crompton Greaves has target of Rs 225-220: Thukral
Strides, Pfizer to deal post US FDA nod on Oncology unit
Won't cut retail exposure till interest low: Motilal Oswal
IDFC says execution challenges in infra projects escalating
Infosys top-brass reshuffle not purely ornamental: Analyst
HyperCity margin pressure will get contained: Shoppers Stop
Sterlite Tech eyes 32-35% revenue increase ahead
Will maintain margins as cotton prices slip: Alok Ind
Bajaj Auto will not take any more price hikes for now
Crompton Greaves has target of Rs 225-220: Thukral
Strides, Pfizer to deal post US FDA nod on Oncology unit
Won't cut retail exposure till interest low: Motilal Oswal
IDFC says execution challenges in infra projects escalating
Infosys top-brass reshuffle not purely ornamental: Analyst
HyperCity margin pressure will get contained: Shoppers Stop
Sterlite Tech eyes 32-35% revenue increase ahead
Will maintain margins as cotton prices slip: Alok Ind
Bajaj Auto will not take any more price hikes for now
Crompton Greaves has target of Rs 225-220: Thukral
